List of Studies ( Metabolite:PC P-32:1 or PC O-32:2)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004093 | AN006783 | Autoimmune Disease Risk Gene ANKRD55 Promotes T Cell Proliferation and Th17 2 Effector Function Through Metabolic Modulation | T-cells | Mouse | Autoimmune disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003103 | AN005077 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Blood | Human | COVID-19 | Universidad CEU San Pablo | GC-MS/LC-MS |
| ST003058 | AN005013 | Spatiotemporal mapping of lipid disturbance in heart injury - Part 2 | Blood | Mouse | Heart injury | National University of Singapore | LC-MS |
| ST002700 | AN004376 | Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics | Blood | Human | Autism | Columbia University | LC-MS |
| ST002545 | AN004192 | Lipidomic profile of Toxoplasma gondii-infected mice (Positive mode MS) | Blood | Mouse | Cachexia | University of Virginia | LC-MS |
| ST002023 | AN003293 | A targeted metabolomics study for assessing rodent thyroid toxicity | Liver | Rat | Thyroid toxicity | Helmholtz Centre for Environmental Research | LC-MS |
| ST002023 | AN003293 | A targeted metabolomics study for assessing rodent thyroid toxicity | Thyroid | Rat | Thyroid toxicity | Helmholtz Centre for Environmental Research | LC-MS |
| ST002002 | AN003265 | A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 3) | Blood | Human | Myalgic encephalomyelitis/chronic fatigue syndrome | Columbia University | LC-MS |
| ST001949 | AN003173 | Plasma Metabolome Normalization in Rheumatoid Arthritis following initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy | Blood | Human | Rheumatoid arthritis | University of Kansas | GC-MS |
| ST001942 | AN003185 | Lipidomics of esophageal adenocarcinoma | Esophagus | Human | Cancer | QIMR Berghofer Medical Research Institute | LC-MS |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Blood | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001843 | AN002986 | Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) | Liver | Human | Fatty liver disease | University of California, Davis | GC-MS |
| ST001836 | AN002978 | Quantitative lipids study on blood serum and ceacal content of rat models | Blood | Rat | Helmholtz Centre for Environmental Research | LC-MS | |
| ST001836 | AN002978 | Quantitative lipids study on blood serum and ceacal content of rat models | Cecum | Rat | Helmholtz Centre for Environmental Research | LC-MS | |
| ST001815 | AN002946 | Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | GC-MS/LC-MS |
| ST001396 | AN002335 | Quantitative Lipids study on total murine liver tissue from mice at different age | Liver | Mouse | Helmholtz Centre for Environmental Research | LC-MS | |
| ST001246 | AN002070 | TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes (part-I) | Cultured cells | Human | Sudden infant death syndrome | University of California, Davis | LC-MS |
| ST001211 | AN002018 | Metabolomic Markers of Methotrexate Response, In Vitro | Cultured cells | Human | University of Kansas | GC-MS/LC-MS | |
| ST001113 | AN001809 | Exposure to Oral Contraceptives Alters Human Endometrial Stem Cells Culture Media Metabolomics | Stem cells | Human | Universidade Federal de Sao Paulo | MS(Dir. Inf.) | |
| ST001102 | AN001791 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-II) | Whole animals | Dungeness crab | NOAA NWFSC | LC-MS | |
| ST000991 | AN001617 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) | Blood | Human | University of California, Davis | LC-MS | |
| ST000990 | AN001616 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000989 | AN001615 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) | Blood | Human | University of California, Davis | LC-MS | |
| ST000987 | AN001613 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) | Blood | Human | University of California, Davis | LC-MS | |
| ST000984 | AN001610 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) | Blood | Human | University of California, Davis | LC-MS | |
| ST000983 | AN001609 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) | Blood | Human | University of California, Davis | LC-MS | |
| ST000550 | AN000840 | Metabolomics marker of brown adipose tissue in men | Adipose tissue | Human | Leiden University Medical Center | LC-MS |
